In a surprising twist, two of the most unlikely allies – billionaire Elon Musk and Sen. Bernie Sanders – are standing together on one issue: the high cost of health care in America. Both agree that ...

When Nvidia (NVDA) reported $30 billion in revenue in its second-quarter earnings results, the AI chipmaker disclosed that ...

Plus the week included a stop in Detroit by Lael Brainard, the director of the National Economic Council, who spoke to the ...

In this Saturday version of Insider Today, we're talking about Austin, Texas' real estate cycle and the price of weight-loss ...

On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard ...

About 40% of U.S. adults suffer from obesity, and the cost of covering GLP-1 agonists and related anti-obesity drugs can be ...

Sen. Bernie Sanders’ aggressive targeting of Danish drugmaker Novo Nordisk’s Ozempic and Wegovy pricing, and not Eli Lilly’s ...

On Capitol Hill lawmakers grilled the CEO of the company that makes popular weight loss drugs Ozempic and Wegovy.

Sen. Bernie Sanders (I-Vt.) noted that Novo Nordisk’s weight loss drug Ozempic sells for $969 a month in the U.S. but for ...

Fox News anchor Bret Baier has pointed the finger at former President Donald Trump, not Vice President Kamala Harris, for the ...

If these preliminary findings are more widely applicable, opioid use disorder would be added to the long list of ailments potentially reduced by Ozempic.

The Senate Committee on Health, Education, Labor and Pensions held a hearing on Tuesday, to discuss Novo Nordisk lowering ...